# Demonstrate Exubera Works As Well As Avandia When Added To Sulfonylurea + Metformin In Controlling Glucose

> **NCT00150410** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 626 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** Inhaled insulin

## Key facts

- **NCT ID:** NCT00150410
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** —
- **Final completion:** 2007-06
- **Target enrollment:** 626 (ACTUAL)
- **Last updated:** 2008-10-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00150410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00150410, "Demonstrate Exubera Works As Well As Avandia When Added To Sulfonylurea + Metformin In Controlling Glucose". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00150410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*